Theromics Revenue and Competitors
Estimated Revenue & Valuation
- Theromics's estimated annual revenue is currently $1.7M per year.
- Theromics's estimated revenue per employee is $242,857
- Theromics's total funding is $3.4M.
Employee Data
- Theromics has 7 Employees.
- Theromics grew their employee count by 40% last year.
Theromics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & Chief Medical Officer | Reveal Email/Phone |
2 | C.E.O. | Reveal Email/Phone |
Theromics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 17 | 0% | N/A | N/A |
#2 | N/A | 4 | 0% | N/A | N/A |
#3 | $7.5M | 114 | 7% | N/A | N/A |
#4 | $7.5M | 72 | 33% | N/A | N/A |
#5 | N/A | 17 | 55% | N/A | N/A |
#6 | $7.5M | 48 | -2% | N/A | N/A |
#7 | N/A | 32 | 33% | N/A | N/A |
#8 | N/A | 115 | 37% | N/A | N/A |
#9 | $1.7M | 9 | -18% | N/A | N/A |
#10 | N/A | 70 | -17% | N/A | N/A |
What Is Theromics?
Theromics has developed a novel, safe, Thermal Accelerant (TA) called HeatSYNC TA. The HeatSYNC TA is used during microwave and radiofrequency ablations of cancerous tumors. HeatSYNC can augment the reach of thermal energy from a distance normally unattainable by microwave or radiofrequency devices, thus high-power energy is not needed. “Caution: This device is for Investigational Use Only and has not been cleared by the FDA or other regulatory bodies.”
keywords:N/A$3.4M
Total Funding
7
Number of Employees
$1.7M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 8 | 14% | N/A |
#2 | $3M | 12 | -8% | N/A |
#3 | $4.7M | 25 | 0% | N/A |
#4 | $4M | 25 | 0% | N/A |
#5 | $6.5M | 26 | 8% | N/A |